Lipinski et al. found that increased FAK activity was correlated with high proliferation and low migration rates in four different human GBM cell lines, suggesting that FAK is an important signaling effector in gliomas, and its regulation may be a determinant of proliferative development or migratory phenotype [73]. The gene discussed is PTK2; the disease is central nervous system cancer.